2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Personality Disorders: new trials by email Literature Review of Personality Disorders trials Research Report on Personality Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| "Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients" N-Acetylcysteine, Placebo, IPPI (Integrated Preventive Psychological Intervention) - Prodromal Schizophrenia | Phase 3 | Terminated | University Hospital, Bonn | 48 | 2016-09-01 | 2022-05-09 |
| Naltrexone in Borderline Personality Disorder Naltrexone - Borderline Personality Disorder | Phase 3 | Terminated | Central Institute of Mental Health, Mannheim | 48 | 2005-10-01 | 2008-04-15 |
Borderline Personality Disorder (1) · Dissociative Disorders (1) · Schizophrenia (1) · Schizotypal Personality Disorder (1) · Self-Injurious Behavior (1)
Mental Disorders (2) · Behavior (1) · Behavioral Symptoms (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1)
Acetylcysteine (1) · Naltrexone (1)
Central Institute of Mental Health, Mannheim (1) · University Hospital, Bonn (1)
Germany (2)